TrialMetabolic brain disease2009

Changes in erythrocyte membrane fatty acids during a clinical trial of eicosapentaenoic acid (EPA) supplementation in schizophrenia.

Susan J van Rensburg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.